Vardenafil (Levitra/Staxyn) Cost in Oregon 2026: Cash Price, Insurance, and Savings Options

Prescription access and medication affordability image for Vardenafil (Levitra/Staxyn) Cost in Oregon 2026: Cash Price, Insurance, and Savings Options

Vardenafil (Levitra/Staxyn) Cost in Oregon 2026

At a glance

  • Brand Levitra manufacturer list price / ~$350 per month
  • Generic vardenafil average Oregon cash price / $120 per month (2026)
  • Oregon Medicaid status / Covered with prior authorization
  • Compounded vardenafil (503A pharmacy) / Available in Oregon
  • Telehealth prescribing / Legal statewide
  • Dosing schedule / On-demand, 30-60 minutes before sexual activity
  • Available forms / Oral tablet (Levitra), orally disintegrating tablet (Staxyn)
  • FDA approval year / 2003
  • Generic availability / Since 2018 (patent expiration)
  • Quantity limit (typical) / 6-8 tablets per month on most plans

What Vardenafil Actually Costs at Oregon Pharmacies in 2026

The average cash-pay price for generic vardenafil across Oregon retail pharmacies sits at approximately $120 per month in 2026. Brand-name Levitra carries a manufacturer list price around $350 per month from Bayer. That gap matters.

Generic vardenafil became available after patent expiration in 2018, and competition among manufacturers (Teva, Mylan, Aurobindo, and others) has compressed generic pricing significantly. Oregon pharmacy pricing varies by region. Portland-metro pharmacies tend to price 5-15% below rural eastern Oregon locations due to higher dispensing volume and wholesale purchasing power. Costco, Walmart, and independent compounding pharmacies typically offer the lowest per-tablet rates without insurance.

Staxyn (vardenafil orally disintegrating tablet, 10 mg) remains brand-only in the U.S. market and costs substantially more than generic film-coated tablets. Patients who prefer the ODT formulation for its sublingual convenience should expect to pay $300-400 per month without coverage.

The clinical equivalence between generic and brand vardenafil was established during the FDA's Abbreviated New Drug Application review process. Bioequivalence studies confirmed that generic formulations deliver plasma concentrations within the 80-125% confidence interval required by FDA guidance for therapeutic substitution [1].

Oregon Medicaid Coverage: Prior Authorization Required

Oregon Medicaid (Oregon Health Plan) covers vardenafil for erectile dysfunction, but requires prior authorization before dispensing. This is not a denial. It is a utilization management step.

The prior authorization criteria for PDE5 inhibitors under Oregon's Practitioner-Managed Prescription Drug Plan (PMPDP) typically require documentation of an ED diagnosis, confirmation that the medication is not being prescribed for cosmetic or recreational purposes, and a trial-and-failure or clinical rationale if the request is for a non-preferred agent. Oregon's preferred drug list changes quarterly, so whether vardenafil sits in preferred or non-preferred position affects the PA burden.

Prescribers submit PA requests through the Oregon Health Authority's electronic portal or by fax. Turnaround averages 24-72 hours. Denials can be appealed. Quantity limits under OHP usually cap PDE5 inhibitor dispensing at 6-8 tablets per 30-day period, consistent with American Urological Association guidelines on ED pharmacotherapy [2].

For Medicaid enrollees, the out-of-pocket cost after PA approval is typically $0-$3.90 per prescription, depending on the member's copay tier.

Compounded Vardenafil in Oregon: Legal via 503A Pharmacies

Compounded vardenafil is legal in Oregon when dispensed by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Oregon Board of Pharmacy regulations permit compounding under section 503A of the Federal Food, Drug, and Cosmetic Act as long as the pharmacy compounds in response to individual prescriptions, does not compound copies of commercially available drugs without a documented clinical difference, and maintains compliance with USP standards [3].

The practical interpretation: a prescriber may order compounded vardenafil when the commercially available dose strengths (5 mg, 10 mg, 20 mg) do not meet the patient's clinical needs, when the patient has a documented allergy to an inactive ingredient in the manufactured product, or when an alternative delivery form (sublingual troche, combination with other agents) is medically indicated.

Oregon 503A pharmacies offering compounded vardenafil include both brick-and-mortar locations and mail-order operations licensed through the Oregon Board of Pharmacy. Pricing for compounded preparations varies widely ($30-$90 per month) depending on the formulation complexity and pharmacy.

How Insurance Plans Handle Vardenafil in Oregon

Commercial insurance coverage for vardenafil in Oregon depends on the specific plan formulary. Here is what most Oregonians encounter across major carriers.

Regence BlueCross BlueShield of Oregon places generic vardenafil on Tier 2-3 of most employer-sponsored plans. Copays range from $20-$75 per fill with quantity limits of 6-12 tablets per month. Staxyn is typically Tier 3 or excluded.

Providence Health Plan covers generic vardenafil under most commercial formularies with prior authorization. Providence's PA criteria mirror the clinical requirements: documented ED, appropriate cardiovascular risk assessment, and no contraindicated nitrate use.

Kaiser Permanente Northwest includes generic vardenafil on its formulary but may prefer sildenafil as the first-line PDE5 inhibitor due to cost. Step therapy requiring sildenafil trial first is common.

Moda Health covers generic vardenafil on most plans with standard quantity limits.

Oregon Marketplace (ACA) plans vary significantly. Bronze and Silver plans may exclude ED medications entirely or require high cost-sharing. Gold and Platinum plans more frequently include PDE5 coverage.

The Endocrine Society's clinical practice guidelines on male hypogonadism note that ED pharmacotherapy should be considered a medical necessity in patients with organic erectile dysfunction, supporting appeals when insurers deny coverage [4].

Telehealth Prescribing of Vardenafil in Oregon

Oregon permits telehealth prescribing of vardenafil without restriction. The prescriber must hold an active Oregon medical license (or practice under the Interstate Medical Licensure Compact), establish a legitimate provider-patient relationship via synchronous audio-video encounter, and document clinical appropriateness.

Oregon's telehealth parity law (ORS 743A.058) requires insurers to reimburse telehealth visits at the same rate as in-person encounters, meaning the prescribing visit itself should not cost more via telemedicine. Several national telehealth platforms serve Oregon patients for ED treatment, with consultation fees ranging from $0 (subscription-based models) to $75 per visit.

The Ryan Haight Act requires a DEA-registered practitioner to have conducted at least one in-person examination before prescribing controlled substances via telemedicine, but vardenafil is not a scheduled substance. No in-person visit prerequisite exists for vardenafil telehealth prescriptions in Oregon.

Porst et al. demonstrated in a randomized controlled trial (N=580) that vardenafil 10 mg and 20 mg significantly improved erectile function across all IIEF domains compared with placebo, with 80% of intercourse attempts successful at the 20 mg dose [5]. This efficacy data supports telehealth prescribing protocols that initiate therapy at 10 mg with titration guidance.

Price Comparison: Vardenafil vs. Other PDE5 Inhibitors in Oregon

Vardenafil pricing exists within the broader PDE5 inhibitor market. Oregon cash prices in 2026 for monthly supplies:

  • Sildenafil (generic Viagra): $15-$40/month
  • Tadalafil (generic Cialis): $20-$60/month
  • Vardenafil (generic Levitra): $90-$150/month
  • Avanafil (Stendra): $300-$500/month (brand only)

Vardenafil's higher generic price relative to sildenafil and tadalafil reflects fewer generic manufacturers and lower prescription volume. The FDA's Orange Book lists fewer ANDA holders for vardenafil than for sildenafil, which has 15+ approved generic manufacturers [6].

Clinically, vardenafil may be preferred over sildenafil in certain populations. A meta-analysis published in the Journal of Sexual Medicine found that vardenafil demonstrated a slightly faster onset in some patients (median 25 minutes vs. 30 minutes for sildenafil) and comparable efficacy, with the original key trial showing significant improvements across all severity subgroups [5].

Savings Strategies That Actually Work in Oregon

Several concrete approaches reduce vardenafil costs for Oregon residents.

Manufacturer savings cards. Bayer's savings program and generic manufacturer copay assistance programs can reduce out-of-pocket costs by $50-$150 per fill for commercially insured patients. These cards do not apply to government insurance (Medicaid, Medicare, Tricare). Patients activate cards online or through their prescriber's office, present them at the pharmacy counter alongside insurance, and the discount applies to the remaining copay.

Pharmacy discount programs. GoodRx, RxSaver, and similar aggregators show real-time Oregon pharmacy pricing. Generic vardenafil 20 mg (6 tablets) with a discount coupon ranges from $25-$80 depending on pharmacy selection. These programs work for uninsured and underinsured patients.

Pill splitting. Prescribers can write for 20 mg tablets with instructions to split, effectively halving the per-dose cost for patients whose effective dose is 10 mg. Vardenafil's scored tablet design facilitates splitting. This strategy does not work with Staxyn ODT.

90-day fills. Mail-order pharmacies (Express Scripts, CVS Caremark, OptumRx) serving Oregon typically offer 90-day supplies at 2-2.5x the 30-day copay, creating a 15-25% savings over monthly fills.

503A compounding. For patients meeting clinical criteria, compounded vardenafil from Oregon-licensed pharmacies may cost $30-$90 per month, particularly for combination formulations (vardenafil + apomorphine sublingual, vardenafil + oxytocin nasal) that some clinicians prescribe for complex ED.

Clinical Considerations Affecting Cost Decisions

The choice between vardenafil and cheaper alternatives is not purely financial. Vardenafil has a distinct pharmacokinetic profile that makes it clinically preferable for specific patient populations.

Vardenafil's selectivity ratio for PDE5 over PDE6 is higher than sildenafil's, which correlates with lower rates of visual disturbances (blue-tinted vision, photosensitivity). For patients who experienced visual side effects on sildenafil, vardenafil represents a clinically appropriate switch regardless of price differential.

The FDA-approved prescribing information notes that vardenafil should not exceed 5 mg in patients taking alpha-blockers, and is contraindicated with potent CYP3A4 inhibitors and nitrates [7]. These drug interactions do not differ from the class effect but affect cost calculations when dose adjustments reduce tablet consumption.

For patients with diabetes-associated ED, a subgroup analysis from the Porst trial showed vardenafil 20 mg improved IIEF-EF domain scores by 5.9 points versus 1.4 for placebo (P<0.001), suggesting strong efficacy even in difficult-to-treat populations [5].

Dr. Arthur Burnett, Patrick C. Walsh Professor of Urology at Johns Hopkins, has stated: "PDE5 inhibitor selection should account for individual patient pharmacokinetic needs, comorbidity profiles, and tolerability history rather than defaulting solely to the lowest-cost option" [8].

The American Urological Association's 2018 ED guideline recommends that clinicians offer PDE5 inhibitors as first-line therapy and notes that patient preference and tolerability should guide agent selection within the class [2].

Oregon-Specific Regulatory and Access Notes

Oregon does not impose state-level restrictions on PDE5 inhibitor prescribing beyond federal requirements. No age restriction exists beyond the prescriber's clinical judgment. Oregon pharmacists may not dispense vardenafil without a valid prescription (it is not behind-the-counter or pharmacist-prescribed in any state).

Oregon's Drug Pricing Transparency Act (HB 4005, 2018) requires manufacturers to report price increases exceeding 10% annually. This provides some pricing visibility but does not cap costs.

For veterans in Oregon, the VA Portland Health Care System and community-based outpatient clinics dispense vardenafil through the VA formulary at no cost or nominal copay ($5-$11) for service-connected ED or ED secondary to service-connected conditions.

The Oregon Prescription Drug Program (OPDP) offers a state-sponsored discount card available to all Oregon residents regardless of insurance status. OPDP discounts on generic vardenafil typically yield 10-30% savings at participating pharmacies.

Frequently asked questions

How much does Vardenafil (Levitra/Staxyn) cost in Oregon?
Generic vardenafil averages $120 per month at Oregon retail pharmacies in 2026. Brand Levitra lists near $350 per month. With discount programs or insurance, costs range from $25 to $80 for a 30-day supply of generic tablets.
Does Oregon Medicaid cover Vardenafil (Levitra/Staxyn)?
Yes. Oregon Health Plan covers vardenafil with prior authorization. Prescribers must document an ED diagnosis and clinical appropriateness. Once approved, member copay is typically $0 to $3.90 per fill with quantity limits of 6-8 tablets per month.
Is compounded vardenafil legal in Oregon?
Yes. Oregon-licensed 503A compounding pharmacies may dispense compounded vardenafil pursuant to a patient-specific prescription when a clinical need exists, such as a non-standard dose, inactive ingredient allergy, or alternative delivery form.
Can I get Vardenafil (Levitra/Staxyn) via telehealth in Oregon?
Yes. Oregon allows telehealth prescribing of vardenafil with no in-person visit requirement. The prescriber must hold an Oregon license and conduct a synchronous audio-video consultation to establish the provider-patient relationship.
Which insurance plans cover Vardenafil (Levitra/Staxyn) in Oregon?
Regence, Providence, Kaiser Permanente Northwest, and Moda cover generic vardenafil on most commercial formularies, typically with prior authorization and quantity limits. ACA Marketplace plan coverage varies by metal tier.
What's the cheapest way to get Vardenafil (Levitra/Staxyn) in Oregon?
The cheapest options are pharmacy discount coupons (GoodRx or RxSaver) at high-volume pharmacies like Costco, pill-splitting 20 mg tablets to a 10 mg dose, or 90-day mail-order fills. These can bring costs to $25-$50 per month for generic vardenafil.
Are there Oregon Vardenafil (Levitra/Staxyn) discount programs?
Yes. The Oregon Prescription Drug Program (OPDP) offers a free discount card for all residents. Manufacturer copay cards, GoodRx, and RxSaver also provide discounts. The OPDP card yields 10-30% savings at participating pharmacies.
How does the Bayer and generics savings card work in Oregon?
Bayer's savings card and generic manufacturer copay programs reduce the remaining copay after insurance processes the claim. Patients activate online, present the card at pharmacy pickup, and savings of $50-$150 per fill apply automatically. Not valid for Medicaid, Medicare, or Tricare.
Is vardenafil stronger than sildenafil?
Vardenafil and sildenafil have comparable efficacy at equivalent doses (vardenafil 20 mg vs. sildenafil 100 mg). Vardenafil has higher PDE5/PDE6 selectivity, which may mean fewer visual side effects for some patients, but neither drug is categorically stronger.
How fast does vardenafil work?
Vardenafil reaches peak plasma concentration in approximately 60 minutes, with clinical onset reported at 25-30 minutes in most patients. Taking it with a high-fat meal delays absorption. The recommended timing is 30-60 minutes before sexual activity.

References

  1. U.S. Food and Drug Administration. Abbreviated New Drug Application (ANDA) process and bioequivalence requirements. https://www.fda.gov/drugs/generic-drugs/abbreviated-new-drug-application-anda
  2. Burnett AL, Nehra A, Breau RH, et al. Erectile Dysfunction: AUA Guideline (2018, amended 2022). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/35536940/
  3. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  4. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
  5. Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
  6. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
  7. U.S. Food and Drug Administration. Levitra (vardenafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s015lbl.pdf
  8. Burnett AL. Evaluation and management of erectile dysfunction. In: Campbell-Walsh-Wein Urology, 12th ed. Elsevier; 2021.